Scientists can peer into cells to get a limited view of their activity using microscopes and other tools. However, cells and ...
The RNA therapy market presents opportunities in innovative RNA modalities, personalized medicine demand, and strategic ...
Researchers from Carnegie Mellon University have discovered a way to target RNA that could lead to new treatment options for myotonic dystrophy type 1 (DM1), the most common adult-onset form of ...
Novel hybrid polymer nanocarriers enable effective vaccine delivery in the lungs and the targeted activation of immune cells.
In a unique finding, researchers at Georgetown's Lombardi Comprehensive Cancer Center discovered that when pancreatic cancer ...
Transcriptome-based NGS outperforms traditional viral testing with superior sensitivity, detecting viruses including novel ...
In a unique finding, researchers at Georgetown's Lombardi Comprehensive Cancer Center discovered that when pancreatic cancer ...
Medulloblastoma is one of the most common pediatric brain malignancies. A deeper understanding of the mechanisms underlying ...
Researchers at Ludwig Maximilian University of Munich developed hybrid PLGA-PBAE nanoparticles that delivered mRNA vaccines ...
After a cacophony of troubles hit the RNA editing biotech last fall, CEO Ram Aiyar is in San Francisco to develop ...
The first patient has been dosed in a Phase 2 clinical trial testing RAG-17 in people with ALS who carry mutations in the ...